{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T21:14:45Z","timestamp":1649020485299},"reference-count":31,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2006,9,1]],"date-time":"2006-09-01T00:00:00Z","timestamp":1157068800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2006,9]]},"DOI":"10.1016\/j.lungcan.2006.05.013","type":"journal-article","created":{"date-parts":[[2006,7,12]],"date-time":"2006-07-12T09:34:59Z","timestamp":1152696899000},"page":"355-360","source":"Crossref","is-referenced-by-count":3,"title":["Gemcitabine (GEM) and Vindesine (VDS) in advanced non-small cell lung cancer (NSCLC): A phase II study in elderly or poor performance status patients"],"prefix":"10.1016","volume":"53","author":[{"given":"Antonio","family":"Santo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovenzio","family":"Genestreti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Terzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Azzoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teodoro","family":"Sava","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pietro","family":"Manno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annamaria","family":"Molino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristian","family":"Pattaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rocco","family":"Micciolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gian Luigi","family":"Cetto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.lungcan.2006.05.013_bib1","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1002\/(SICI)1097-0142(19960501)77:9<1947::AID-CNCR27>3.0.CO;2-Z","article-title":"The National Cancer Data Base report on lung cancer","volume":"77","author":"Fry","year":"1996","journal-title":"Cancer"},{"key":"10.1016\/j.lungcan.2006.05.013_bib2","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1136\/bmj.311.7010.899","article-title":"Chemotherapy in non small cell lung cancer: a meta-analysis using update data on individual patients from 52 randomized clinical trials","volume":"311","author":"Non Small Cell Lung Cancer Cooperative Group","year":"1995","journal-title":"Br Med J"},{"key":"10.1016\/j.lungcan.2006.05.013_bib3","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1056\/NEJM199912303412706","article-title":"Under representation of patients of 65 years of age or older in cancer treatment trials","volume":"341","author":"Hutchins","year":"1999","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.lungcan.2006.05.013_bib4","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0169-5002(98)00039-7","article-title":"Prevalence of comorbidity in lung cancer patients and its relationship with treatment: a population based study","volume":"21","author":"Janssen-Heijnen","year":"1998","journal-title":"Lung Cancer"},{"key":"10.1016\/j.lungcan.2006.05.013_bib5","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1200\/JCO.1998.16.4.1582","article-title":"Comorbidity and functional status are independent in older patients","volume":"16","author":"Extermann","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.lungcan.2006.05.013_bib6","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1111\/j.1349-7006.1995.tb03315.x","article-title":"Prospective evaluation of the feasibility of cisplatin-based chemotherapy for elderly lung cancer patients with normal organ functions","volume":"86","author":"Oshita","year":"1995","journal-title":"Jpn J Cancer Res"},{"key":"10.1016\/j.lungcan.2006.05.013_bib7","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0959-8049(95)00444-0","article-title":"Activity of gemcitabine in patients with non-small cell lung cancer: a multicenter extended phase II study","volume":"32","author":"Gatzemeier","year":"1996","journal-title":"Eur J Cancer"},{"issue":"Suppl 7","key":"10.1016\/j.lungcan.2006.05.013_bib8","first-page":"50","article-title":"Gemcitabine in the treatment of elderly patients with advanced non-small cell lung cancer","volume":"24","author":"Shepherd","year":"1997","journal-title":"Semin Oncol"},{"key":"10.1016\/j.lungcan.2006.05.013_bib9","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1200\/JCO.1994.12.8.1535","article-title":"Efficacy and safety profile of gemcitabine in non small cell lung cancer: a phase II study","volume":"12","author":"Abratt","year":"1994","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.lungcan.2006.05.013_bib10","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1200\/JCO.1997.15.2.744","article-title":"Weekly gemcitabine with monthly cisplatin: effective chemotherapy for advanced non-small cell lung cancer","volume":"15","author":"Abratt","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.lungcan.2006.05.013_bib11","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1200\/JCO.1997.15.1.297","article-title":"Cisplatin\u2013gemcitabine combination in advanced non-small cell lung cancer: a phase II study","volume":"15","author":"Crino","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.lungcan.2006.05.013_bib12","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/BF00874146","article-title":"Is there a role for vindesine in the treatment of non-small cell lung cancer","volume":"11","author":"Sorensen","year":"1993","journal-title":"Invest New Drugs"},{"issue":"4","key":"10.1016\/j.lungcan.2006.05.013_bib13","first-page":"387","article-title":"Randomized trial comparing vindesine plus cisplatin with vinblastine and cisplatin in patients with non small cell lung cancer, with an analysis of methods of response assessment","volume":"69","author":"Kris","year":"1985","journal-title":"Cancer Treat Rep"},{"key":"10.1016\/j.lungcan.2006.05.013_bib14","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/sj.bjc.6690140","article-title":"Phase II study of gemcitabine and vindesine in patients with previously untreated non-resectable non-small cell lung cancer","volume":"79","author":"Sorensen","year":"1999","journal-title":"Br J Cancer"},{"key":"10.1016\/j.lungcan.2006.05.013_bib15","unstructured":"WHO handbook for reporting results of cancer treatment. Geneva (Switzerland): World Health Organization Offset Publication No. 48; 1979."},{"issue":"6","key":"10.1016\/j.lungcan.2006.05.013_bib16","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1200\/JCO.1997.15.6.2403","article-title":"Improvement in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial","volume":"15","author":"Burris","year":"1997","journal-title":"J Clin Oncol"},{"issue":"6 Suppl 11","key":"10.1016\/j.lungcan.2006.05.013_bib17","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1053\/j.seminoncol.2004.10.005","article-title":"Drug development in patients with advanced non small cell lung cancer and poor performance status","volume":"31","author":"Stinchcombe","year":"2004","journal-title":"Semin Oncol"},{"key":"10.1016\/j.lungcan.2006.05.013_bib18","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0959-8049(95)00444-0","article-title":"Activity of gemcitabine on patients with non-small cell lung cancer: a multicenter extended phase II study","volume":"32","author":"Gatzemeier","year":"1996","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.lungcan.2006.05.013_bib19","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/S0959-8049(97)89011-9","article-title":"Vinorelbine is well tolerated and active in the treatment of elderly patients with advanced non-small cell lung cancer. A two-stage phase II study","volume":"33","author":"Gridelli","year":"1997","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.lungcan.2006.05.013_bib20","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1093\/jnci\/91.1.66","article-title":"Effects of vinorelbine on quality of life and survival of elderly patients with advanced non-small cell lung cancer","volume":"91","author":"The Elderly Lung Cancer Vinorelbine Italian Study Group","year":"1999","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"10.1016\/j.lungcan.2006.05.013_bib21","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1001\/jama.292.4.470","article-title":"Benefits of adding a drug to a single-agent or a 2-agent chemotherapy regimen on advanced non-small cell lung cancer: a meta-analysis","volume":"292","author":"Delbaldo","year":"2004","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.lungcan.2006.05.013_bib22","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1054\/bjoc.2000.1341","article-title":"Gemcitabine plus vinorelbine in advanced non-small cell lung cancer: a phase II study of three different doses. Gem Vin Investigators","volume":"83","author":"Gridelli","year":"2000","journal-title":"Br J Cancer"},{"issue":"5","key":"10.1016\/j.lungcan.2006.05.013_bib23","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1054\/bjoc.2000.1304","article-title":"Gemcitabine plus vinorelbine in elderly or unfit patients with non-small cell lung cancer","volume":"83","author":"Beretta","year":"2000","journal-title":"Br J Cancer"},{"issue":"3","key":"10.1016\/j.lungcan.2006.05.013_bib24","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1002\/(SICI)1097-0142(20000201)88:3<557::AID-CNCR10>3.0.CO;2-5","article-title":"Gemcitabine and vinorelbine in advanced non-small cell lung carcinoma","volume":"88","author":"Lilenbaum","year":"2000","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.lungcan.2006.05.013_bib25","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1002\/1097-0142(20000815)89:4<763::AID-CNCR7>3.0.CO;2-F","article-title":"Gemcitabine plus vinorelbine as first-line chemotherapy in advanced non-small cell lung carcinoma: a phase II trial","volume":"89","author":"Bajetta","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.lungcan.2006.05.013_bib26","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0169-5002(01)00206-9","article-title":"Gemcitabine plus vinorelbine in stage IIIB or IV non-small cell lung cancer (NSCLC): a multicenter phase II trial","volume":"34","author":"Palmeri","year":"2002","journal-title":"Lung Cancer"},{"issue":"5","key":"10.1016\/j.lungcan.2006.05.013_bib27","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1093\/jnci\/95.5.362","article-title":"Chemotherapy for elderly patients with advanced non-small cell lung cancer: the Multicenter Italian Lung Cancer in the Elderly Study (MILES) phase III randomized trial","volume":"95","author":"Gridelli","year":"2003","journal-title":"J Natl Cancer Inst"},{"issue":"13","key":"10.1016\/j.lungcan.2006.05.013_bib28","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1200\/JCO.2000.18.13.2529","article-title":"Gemcitabine plus vinorelbine versus vinorelbine alone in elderly patients with advanced non-small cell lung cancer","volume":"18","author":"Frasci","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.lungcan.2006.05.013_bib29","doi-asserted-by":"crossref","unstructured":"Abratt RP, Szczesna A, Mattson K, Wernli M, Reiterer P, Hui R, et al. Vinorelbine (NVB)\u2013carboplatin (CBDCA) vs non-platinum doublets in inoperable non-small cell lung cancer (NSCLC) patients (pts)\u2014final results of the Glob 2 phase III with patients benefit analysis. Proc Am Clin Oncol; 2004.","DOI":"10.1200\/jco.2004.22.14_suppl.7016"},{"issue":"Suppl 7","key":"10.1016\/j.lungcan.2006.05.013_bib30","first-page":"7","article-title":"In vitro interaction between gemcitabine and other anticancer drugs using a novel three-dimensional model","volume":"24","author":"Kanzawa","year":"1997","journal-title":"Semin Oncol"},{"key":"10.1016\/j.lungcan.2006.05.013_bib31","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1093\/oxfordjournals.annonc.a010760","article-title":"Randomized study of vinorelbine (VRB) versus vindesine (VDS) in previously untreated stage IIIB or IV non-small cell lung cancer (NSCLC)","volume":"7","author":"Furuse","year":"1996","journal-title":"Ann Oncol"}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500206002728?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500206002728?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,19]],"date-time":"2019-04-19T20:11:08Z","timestamp":1555704668000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169500206002728"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,9]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,9]]}},"alternative-id":["S0169500206002728"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2006.05.013","relation":{},"ISSN":["0169-5002"],"issn-type":[{"value":"0169-5002","type":"print"}],"subject":[],"published":{"date-parts":[[2006,9]]}}}